Chronic Coronary Disease Clinical Trial
Official title:
One Month Dual Antiplatelet Therapy With Ticagrelor in Coronary Artery Bypass Graft Patients
The purpose of this study is to compare the effect of ticagrelor versus placebo in patients with chronic coronary disease undergoing coronary artery bypass grafting.
A multinational, randomized, double-blind, placebo-controlled trial to evaluate the effect of one-month ticagrelor twice daily in addition to low-dose aspirin on the incidence of death, myocardial infarction, stroke, repeat revascularization and graft failure in patients with chronic coronary disease undergoing coronary artery bypass grafting. ;